Oral administration of diclofenac in the prevention of post-ERCP pancreatitis: A double-blind, multicenter study.
Not Applicable
- Conditions
- post-ERCP pancreatitis
- Registration Number
- JPRN-UMIN000008109
- Lead Sponsor
- The 4th department of internal medicine, Sapporo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 430
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with hypersensitivity to diclofenac. 2) Patients with performance status 4. 3) Patients who are treated with diclofenac or received diclofenac within a week. 4) Patients with a history of EST and EPBD. 5) Patients with Vater tumor 6) Patients with divism 7) Patients with chronic pancreatitis 8) Patients with biliary pancreatitis 9) Patients who are judged inappropriate by chief (responsive) medical examiner.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method incidence rate of post-ERCP pancreatitis
- Secondary Outcome Measures
Name Time Method